NCT03224026View on ClinicalTrials.gov

Validation of a Proteomic Signature and Assessment of Viremia in Children With Fever Without Source

CompletedOBSERVATIONAL
Enrollment

206

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

August 31, 2018

Conditions
Infectious DiseaseFeverViremia
Trial Locations (1)

Unknown

Geneva University Hospitals, Geneva

Sponsors
All Listed Sponsors
collaborator

University Hospital, Geneva

OTHER

lead

MeMed Diagnostics Ltd.

INDUSTRY

NCT03224026 - Validation of a Proteomic Signature and Assessment of Viremia in Children With Fever Without Source | Biotech Hunter | Biotech Hunter